Julien Charpentier

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Angiotensin Converting Enzyme

Mechanical Ventilation

Acute Respiratory Distress Syndrome

Top Venues

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Driss Laghlam, Anis Chaba, Matthias Tarneaud, Julien Charpentier, Jean-Paul Mira, Frédéric Pène, Clara Vigneron
Survival Benefit of Renin-Angiotensin System Blockers in Critically Ill Cancer Patients: A Retrospective Study. Cancers 15 (12) (2023)
Clara Vigneron, Julien Charpentier, Florence Coussy, Jérôme Alexandre, Frédéric Pène, Matthieu Jamme
When breast cancer comes to the ICU: outcomes and prognostic factors. Acta oncologica (Stockholm, Sweden) (2023)
Driss Laghlam, Anis Chaba, Matthias Tarneaud, Julien Charpentier, Jean-Paul Mira, Frédéric Pène, Clara Vigneron
Survival Benefit of Renin-Angiotensin System Blockers in Critically Ill Cancer Patients: A Retrospective Study. Cancers 15 (12) (2023)
Clara Vigneron, Valentine Le Stang, Justine Decroocq, Edwige Péju, Barbara Burroni, Nicolas Chapuis, Julien Charpentier, Frédéric Pène
Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosis. Acta oncologica (Stockholm, Sweden) 61 (5) (2022)